# Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%

> **NCT02667561** · PHASE1 · WITHDRAWN · sponsor: **Biolab Sanus Farmaceutica**

## Conditions studied

- Post-menopausal Period

## Interventions

- **DRUG:** Testosterone gel 1% 2.2 mg
- **DRUG:** Testosterone gel 1% 4.4 mg
- **DRUG:** Testosterone gel 1% 8.8 mg
- **DRUG:** Placebo of Testosterone Gel 1%

## Key facts

- **NCT ID:** NCT02667561
- **Lead sponsor:** Biolab Sanus Farmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-07
- **Primary completion:** 2017-12
- **Final completion:** 2018-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study has been cancelled and it has not been initiated.
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02667561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02667561, "Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02667561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*